Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study
Top Cited Papers
- 15 November 2000
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 18 (22), 3748-3757
- https://doi.org/10.1200/jco.2000.18.22.3748
Abstract
PURPOSE: To compare the efficacy and tolerability of anastrozole (Arimidex; AstraZeneca, Wilmington, DE, and Macclesfield, United Kingdom) with that of tamoxifen as first-line therapy for advanced ...Keywords
This publication has 26 references indexed in Scilit:
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI Journal of the National Cancer Institute, 1998
- Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinomaCancer, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Stat Bite: Top 5 Cancers for Females and Males in the U.S.JNCI Journal of the National Cancer Institute, 1995
- Effects of Tamoxifen on Cardiovascular Risk Factors in Postmenopausal Women After 5 Years of TreatmentJNCI Journal of the National Cancer Institute, 1994
- Cardiac and Thromboembolic Morbidity Among Postmenopausal Women With Early Stage Breast Cancer in a Randomized Trial of Adjuvant TamoxifenJNCI Journal of the National Cancer Institute, 1993
- Cancer statistics, 1993CA: A Cancer Journal for Clinicians, 1993
- Cancer in the European community and its member statesEuropean Journal of Cancer and Clinical Oncology, 1990
- Antioestrogens in the management of hormone-dependent cancerCancer Treatment Reviews, 1988
- Endocrine Therapy of Advanced Breast CancerActa Oncologica, 1988